Related Experiment Videos
The role of radionuclide studies in breast cancer
1Department of Nuclear Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
Nuclear Medicine Communications
|March 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.
European journal of nuclear medicine and molecular imaging·2006
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases.
British journal of cancer·2001
Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with (131)I.
The British journal of radiology·2001
62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.
European journal of nuclear medicine·2001
False positive 131I whole body scans in thyroid cancer.
The British journal of radiology·2000
Comprehensive acceptance testing and quality control of Single Photon Emission Computed Tomography/Computed Tomography systems.
Nuclear medicine communications·2026
Fluorodeoxyglucose PET/CT-derived Metabolic Peritoneal Cancer Index for survival assessment in peritoneal carcinomatosis.
Nuclear medicine communications·2026
The utility of 18F-fluorodeoxyglucose PET/computed tomography in relapsing polychondritis: a systematic review and meta-analysis.
Nuclear medicine communications·2026
Application of magnetic hyperthermia in prostate cancer treatment.
Acta of bioengineering and biomechanics·2026
Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges.
Frontiers in pharmacology·2026
Rectovaginal fistulas after radiation therapy: treatment options and outcomes - a narrative review.
Frontiers in oncology·2026
Radiation resistance is a property of long-lived plasma cells but not their precursors.
Immunotherapy advances·2026